Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pancras C.W. Hogendoorn(Leiden University Medical Center), Nick Athanasou, S. Bielack(Fondazione IRCCS Istituto Nazionale dei Tumori), E. De Alava, Angelo Paolo Dei Tos, S. Ferrari(Fondazione IRCCS Istituto Nazionale dei Tumori), Hans Gelderblom(Leiden University Medical Center), R. J. Grimer, Kirsten Sundby Hall, A. Bassim Hassan(Université Claude Bernard Lyon 1), Pancras C.W. Hogendoorn(Leiden University Medical Center), Heribert Jürgens(Leiden University Medical Center), Michael Paulussen, L. B. Rozeman(Université Claude Bernard Lyon 1), A. H. M. Taminiau, Jeremy Whelan(Université Claude Bernard Lyon 1), D. Vanel(Leiden University Medical Center)
Annals of Oncology
May 1, 2010
10.1093/annonc/mdq223
Cited by 717Open Access
Full Text

Abstract

Related Papers

Pathology and genetics of tumours of soft tissue and bone
Christopher D.�M. Fletcher, K. Krishnan Unni, Fredrik Mertens|IARC Press eBooks|2002|2.1k
The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.
Henry J. Mankin, Thomas Lange, Suzanne S. Spanier|Journal of Bone and Joint Surgery|1982|644
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
M. Nesbit, E. Gehan, E. Omer Burgert et al.|Journal of Clinical Oncology|1990|577
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Karen H. Antman, John Crowley, S P Balcerzak et al.|Journal of Clinical Oncology|1993|481
Prognostic Factors in Nonmetastatic Ewing’s Sarcoma of Bone Treated With Adjuvant Chemotherapy: Analysis of 359 Patients at the Istituto Ortopedico Rizzoli
Gaetano Bacci, Stefano Ferrari, Franco Bertoni et al.|Journal of Clinical Oncology|2000|325